Biotech Acquisition (OTCMKTS:BIOTU – Get Free Report) was down 7.7% on Friday. The company traded as low as $10.14 and last traded at $10.14. Approximately 1,300 shares were traded during trading, a decline of 71% from the average session volume of 4,444 shares. The stock had previously closed at $10.98.
Biotech Acquisition Price Performance
The business has a 50 day moving average price of $10.14 and a 200-day moving average price of $10.14.
Biotech Acquisition Company Profile
Biotech Acquisition Company is a special purpose acquisition company (SPAC) formed to identify and complete a business combination with a company in the biotechnology, biopharmaceutical, medical device or related life sciences industries.
Unlike an operating biotechnology company, Biotech Acquisition Company does not appear to develop or commercialize its own medicines, therapies or medical products. Its activities have centered on evaluating potential merger, acquisition or similar transactions that could provide a target company with access to public markets.
Publicly available information about the company’s operations, geographic reach, leadership and transaction history is limited.
See Also
- Five stocks we like better than Biotech Acquisition
- Spotify Soars After Earnings as the Company Touts AI Benefits and Moderating Costs
- Lockheed Martin’s Record $292 Billion Backlog Comes With a Delivery Test
- Palantir’s Next Big Test Isn’t a Partnership—It’s the Numbers
- Kinder Morgan’s $4.7 Billion Pipeline Bet Could Be Bigger Than Its Earnings Beat
Receive News & Ratings for Biotech Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biotech Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.
